SecSonar.com

Jazz Pharmaceuticals plc (JAZZ)

Jazz Pharmaceuticals plc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Jazz Pharmaceuticals plc (JAZZ) is a Biotechnology company based in IE with a market capitalization of $14.6B. Revenue grew 4.9% year-over-year and the company generated $1.3B in free cash flow. This page tracks JAZZ's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IE · 2.8K employees · IPO Jun 1, 2007

Valuation

Valuation & price

$237.51 · as of May 26, 2026 · -1.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

3.38

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$240$173$106Jul 25Dec 25Jun 26Jul 7, 25$107.60Jul 9, 25$111.60Jul 11, 25$110.27Jul 15, 25$112.30Jul 17, 25$114.86Jul 21, 25$112.65Jul 23, 25$117.34Jul 25, 25$118.23Jul 29, 25$116.60Jul 31, 25$114.63Aug 4, 25$116.10Aug 6, 25$105.93Aug 8, 25$111.30Aug 12, 25$113.33Aug 14, 25$116.67Aug 18, 25$117.67Aug 20, 25$119.07Aug 22, 25$123.11Aug 27, 25$124.43Aug 29, 25$127.75Sep 3, 25$131.72Sep 5, 25$129.50Sep 9, 25$128.53Sep 11, 25$128.46Sep 15, 25$125.22Sep 17, 25$129.54Sep 19, 25$128.30Sep 23, 25$129.40Sep 25, 25$127.80Sep 29, 25$129.02Oct 1, 25$136.90Oct 3, 25$139.48Oct 7, 25$137.32Oct 9, 25$138.15Oct 13, 25$135.14Oct 16, 25$134.25Oct 20, 25$134.85Oct 22, 25$138.52Oct 24, 25$138.53Oct 28, 25$138.13Oct 30, 25$136.30Nov 3, 25$138.38Nov 5, 25$137.22Nov 7, 25$131.16Nov 11, 25$137.11Nov 13, 25$141.71Nov 17, 25$170.09Nov 19, 25$176.08Nov 21, 25$176.93Nov 25, 25$180.05Nov 28, 25$176.53Dec 2, 25$166.71Dec 5, 25$169.70Dec 9, 25$162.26Dec 11, 25$164.89Dec 15, 25$169.53Dec 17, 25$164.92Dec 19, 25$166.99Dec 23, 25$169.47Dec 26, 25$170.48Dec 30, 25$170.82Jan 2, 26$173.15Jan 6, 26$166.99Jan 8, 26$160.25Jan 12, 26$163.68Jan 14, 26$170.81Jan 16, 26$169.41Jan 21, 26$169.16Jan 23, 26$168.71Jan 28, 26$165.41Jan 30, 26$164.49Feb 3, 26$166.84Feb 5, 26$163.15Feb 9, 26$165.00Feb 11, 26$166.24Feb 13, 26$166.31Feb 18, 26$168.72Feb 20, 26$172.19Feb 24, 26$173.83Feb 26, 26$188.97Mar 2, 26$190.46Mar 4, 26$188.69Mar 6, 26$182.01Mar 10, 26$185.93Mar 12, 26$180.32Mar 16, 26$182.02Mar 19, 26$181.80Mar 23, 26$182.32Mar 25, 26$189.08Mar 27, 26$182.69Mar 31, 26$189.05Apr 2, 26$186.95Apr 7, 26$190.94Apr 9, 26$198.14Apr 13, 26$195.31Apr 15, 26$199.33Apr 17, 26$203.42Apr 21, 26$199.03Apr 23, 26$199.96Apr 27, 26$201.22Apr 29, 26$199.92May 1, 26$202.72May 5, 26$212.26May 8, 26$225.79May 12, 26$227.84May 14, 26$231.05May 18, 26$229.55May 20, 26$239.01May 22, 26$239.83May 27, 26$237.56May 29, 26$236.49Jun 2, 26$226.12Jun 4, 26$240.06Jun 8, 26$232.04Jun 10, 26$229.63Jun 12, 26$230.56Jun 16, 26$226.88Jun 18, 26$224.66Jun 23, 26$230.25Jun 29, 26$234.34
$105.9352-week range$240.06
Loading valuation history…

Fundamentals

Key fundamentals

$14.6B

Market cap

4.9%

Revenue growth (YoY)

88.2%

Gross margin

$1.3B

Free cash flow (USD)

$3B

Net debt

-1.4%

Share dilution

1/6

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.5BFY 2017$1.6BFY 2018$1.9BFY 2019$2.2BFY 2020$2.4BFY 2021$3.1BFY 2022$3.7BFY 2023$3.8BFY 2024$4.1BFY 2025$4.3B
$1.5B$4.3B

Free cash flow by year

2016 → 2025

FY 2016$409.0MFY 2017$579.1MFY 2018$667.4MFY 2019$594.1MFY 2020$520.4MFY 2021$733.0MFY 2022$773.8MFY 2023$1.1BFY 2024$1.3BFY 2025$1.3B
$409M$1.3B

Gross margin by year

2021 → 2025

FY 202185.8%FY 202285.2%FY 202388.6%FY 202489.0%FY 202588.2%
85.8%88.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 5, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventDirector DepartureMay 29, 2026Filing
  • 8-K eventEarnings ReleaseMay 5, 2026Filing
  • Quarterly report10-Q FiledMay 5, 2026Filing
  • Annual report10-K FiledApr 24, 2026Filing

Questions

Frequently asked questions

What is Jazz Pharmaceuticals plc's market cap?

Jazz Pharmaceuticals plc (JAZZ) has a market capitalization of $14.6B.

What is JAZZ's P/E ratio?

A meaningful P/E ratio is not available for JAZZ — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is JAZZ's price-to-book (P/B) ratio?

JAZZ trades at 3.38 times book value per share.

Are insiders buying JAZZ stock?

SEC Form 4 filings show no open-market insider buys at Jazz Pharmaceuticals plc in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

ASND

Ascendis Pharma A/S

$13.7B

NBIX

Neurocrine Biosciences, Inc.

$15.9B

BBIO

BridgeBio Pharma, Inc.

$13.2B

GMAB

Genmab A/S

$16.3B

EXEL

Exelixis, Inc.

$12.9B

IONS

Ionis Pharmaceuticals, Inc.

$12.9B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.